The pharmaceutical drugs commonly prescribed to treat gastroesophageal reflux disease (GERD) have a number of serious side effects. Among other negative effects, proton-pump inhibiting (PPI) drugs can prevent the proper absorption of nutrients by the gastrointestinal system, which makes patients more likely to develop cardiovascular disease. Also known as “acid reflux” and “heartburn,” GERD afflicts four out … Continue reading GERD medication found to disrupt nutrient absorption, increasing the risk of cardiovascular disease
Heartburn drugs (Proton Pump Inhibitors) linked to sudden death risk
Extended use of proton pump inhibitors (PPIs), a popular type of heartburn drug, dramatically increases the risk of death. This was the conclusion of a team of researchers from the Washington University School of Medicine after analyzing medical data of some 300,000 people. Authors of the study say that their findings indicate the need for … Continue reading Heartburn drugs (Proton Pump Inhibitors) linked to sudden death risk
Proton-pump inhibitor drugs for heartburn linked to heart attacks
New research published in the journal PLOS ONE calls into question the safety and effectiveness of a popular class of pharmaceutical drugs used to treat gastroesophageal reflux disease, or GERD, as well as its less extreme companion acid reflux. Researchers found that proton-pump inhibitors, or PPIs, which millions of Americans rely on to treat heartburn symptoms, also … Continue reading Proton-pump inhibitor drugs for heartburn linked to heart attacks
Dr. Eddy Bettermann MD 